Medpace Holdings Inc
Chiusa
SettoreSettore sanitario
459.27 -1.58
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
454.26
Massimo
467.58
Entrata | -11M 124M |
|---|---|
Vendite | -1.8M 707M |
P/E Media del settore | 28.817 49.052 |
EPS | 4.28 |
Margine di Profitto | 17.53 |
Dipendenti | 6,300 |
EBITDA | -16M 148M |
Raccomandazioni | Acquista |
|---|---|
Previsioni per 12 mesi | -3.27% downside |
Utili prossimi | 20 lug 2026 |
|---|
Capitalizzazione di Mercato | -2B 13B |
|---|---|
Apertura precedente | 460.85 |
Chiusura precedente | 459.27 |
Notizie sul Sentiment di mercato
By Acuity
25%
75%
62 / 342 Classifica in Healthcare
Medpace Holdings Inc Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Chi Siamo Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.